Annex

United Kingdom

In Table 1 of the Annex to Regulation (EU) No 37/2010, an entry for the following substance is inserted in alphabetical order:

Pharmacologically active Substance Marker residue Animal Species MRL Target Tissues Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009) Therapeutic Classification
‘Cabergoline Cabergoline Bovine 0,10 μg/kg Fat NO ENTRY Prolactin inhibitor’
0,25 μg/kg Liver
0,50 μg/kg Kidney
0,15 μg/kg Muscle
0,10 μg/kg Milk

Pharmacologically active Substance	Marker residue	Animal Species	MRL	Target Tissues	Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)	Therapeutic Classification
‘Cabergoline	Cabergoline	Bovine	0,10 μg/kg	Fat	NO ENTRY	Prolactin inhibitor’
			0,25 μg/kg	Liver
			0,50 μg/kg	Kidney
			0,15 μg/kg	Muscle
			0,10 μg/kg	Milk